IDT Australia Ltd IDT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.10
- Day Range
- A$0.10–0.10
- 52-Week Range
- A$0.05–0.13
- Bid/Ask
- A$0.10 / A$0.10
- Market Cap
- A$33.74 Mil
- Volume/Avg
- 113,000 / 332,575
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 156
- Website
- https://www.idtaus.com.au
Valuation
|
Metric
|
IDT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.46 |
Price/Sales | 2.77 |
Price/Cash Flow | — |
Price/Earnings
IDT
Financial Strength
|
Metric
|
IDT
|
|---|---|
Quick Ratio | 2.10 |
Current Ratio | 3.24 |
Interest Coverage | — |
Quick Ratio
IDT
Profitability
|
Metric
|
IDT
|
|---|---|
Return on Assets (Normalized) | −23.47% |
Return on Equity (Normalized) | −27.66% |
Return on Invested Capital (Normalized) | −26.52% |
Return on Assets
IDT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hkspjqgmdx | Jgnt | $75.7 Bil | |
MKKGY
| Merck KGaA ADR | Bdgjypbcq | Mshkrc | $71.1 Bil | |
HLN
| Haleon PLC ADR | Ldhzcbzsl | Vkld | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Mdvrchfk | Ykk | $15.9 Bil | |
VTRS
| Viatris Inc | Sqhmpgc | Rmrp | $14.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cvnkmnm | Nggzj | $12.6 Bil | |
CTLT
| Catalent Inc | Yrycykv | Dlhtp | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Lfcbbzht | Mrq | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Sfmrfvjkc | Xrcf | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vdwlgpz | Dmpzvsw | $3.5 Bil |